These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19211266)

  • 1. Relationship between circulating levels of monocyte chemoattractant protein-1 and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Iwasaki J; Nakamura K; Matsubara H; Nakamura Y; Nishii N; Banba K; Murakami M; Ohta-Ogo K; Kimura H; Toh N; Nagase S; Oka T; Morita H; Kusano KF; Ohe T
    Cardiovasc Pathol; 2009; 18(6):317-22. PubMed ID: 19211266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of monocyte chemoattractant protein-1 in idiopathic dilated cardiomyopathy.
    Kobayashi M; Nakamura K; Kusano KF; Nakamura Y; Ohta-Ogo K; Nagase S; Sakuragi S; Ohe T
    Int J Cardiol; 2008 Jun; 126(3):427-9. PubMed ID: 17467829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
    Lehmann MH; Kühnert H; Müller S; Sigusch HH
    Cytokine; 1998 Oct; 10(10):739-46. PubMed ID: 9811526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
    Unno K; Shibata R; Izawa H; Hirashiki A; Murase Y; Yamada T; Kobayashi M; Noda A; Nagata K; Ouchi N; Murohara T
    Heart; 2010 Mar; 96(5):357-61. PubMed ID: 19648128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Nakamura K; Kusano KF; Matsubara H; Nakamura Y; Miura A; Nishii N; Banba K; Nagase S; Miyaji K; Morita H; Saito H; Emori T; Ohe T
    J Card Fail; 2005 Mar; 11(2):117-23. PubMed ID: 15732031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diastolic dysfunction of the left ventricle affected by hypertrophy and abnormal histopathology in hypertrophic cardiomyopathy].
    Sugihara N; Shimizu M; Suematsu T; Horita Y; Shimizu K; Ohsato K; Shibayama S; Nakao T; Kitamura M; Takeda R
    J Cardiol; 1990; 20(1):71-81. PubMed ID: 2151236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advanced sequelae of apical hypertrophic cardiomyopathy: report of two cases with wall motion abnormalities].
    Kusukawa J; Suwa M; Nakayama Y; Hirota Y; Kawamura K; Adachi I; Akagi H
    J Cardiol; 1988 Mar; 18(1):259-69. PubMed ID: 3221316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertrophic cardiomyopathy with left ventricular dilatation].
    Iwami G; Miyazaki Y; Matsuyama K; Shida M; Ooga M; Furuta Y; Ikeda H; Toshima H; Chiba M; Koga Y
    J Cardiol; 1988 Jun; 18(2):319-28. PubMed ID: 3249261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy.
    Kaski JP; Tomé-Esteban MT; Mead-Regan S; Pantazis A; Marek J; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Oct; 94(10):1307-11. PubMed ID: 18070943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function.
    Pieroni M; Corti A; Tota B; Curnis F; Angelone T; Colombo B; Cerra MC; Bellocci F; Crea F; Maseri A
    Eur Heart J; 2007 May; 28(9):1117-27. PubMed ID: 17389654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
    Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
    Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced ST-segment depression and systolic dysfunction in patients with nonobstructive hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Okeie K; Emoto Y; Yamaguchi M; Yasuda T; Fujino N; Fujii H; Fujita S; Mabuchi T; Taki J; Mabuchi H
    Am Heart J; 2000 Jul; 140(1):52-60. PubMed ID: 10874263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
    Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
    Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aortic regurgitation in hypertrophic cardiomyopathy as detected by color Doppler echocardiography].
    Shiota T; Sakamoto T; Amano K; Hada Y; Takenaka K; Hasegawa I; Takahashi T; Suzuki J; Takahashi H; Sugimoto T
    J Cardiol; 1987 Dec; 17(4):759-68. PubMed ID: 3506602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial collagen type I and impaired left ventricular function under exercise in hypertrophic cardiomyopathy.
    Mundhenke M; Schwartzkopff B; Stark P; Schulte HD; Strauer BE
    Thorac Cardiovasc Surg; 2002 Aug; 50(4):216-22. PubMed ID: 12165871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor-alpha soluble receptors type I are related to symptoms and left ventricular function in hypertrophic cardiomyopathy.
    Penicka M; Gregor P; Krupicka J; Jira M
    Can J Cardiol; 2001 Jul; 17(7):777-84. PubMed ID: 11468644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.